Kangstem Biotech | Investors : PR PR Resource Center

본문 바로가기

KOR | ENG

주메뉴

Company
- Company
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Company Overview
- Welcome Message
- Founder
- CEO
- Vision & Mission
- Location
Business
- Business
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Stem Cell Therapy
- FURESTEM-OA Kit Inj.
- FURESTEM-AD® Inj.
- FURESTEM-RA® Inj.
- Advanced Regenerative Medicine
- Organoid
- Skin Organoid
- Islet Organoid
- Stem Cell and CDMO Business
- JUVENTAS
- Stem Cell Culture Business
- CDMO
- Health&Beauty Business
R & D
- R & D
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Core Technology
- Exclusive Technology
- Umbilical Cord Blood Stem Cell
- High-Compact Technology Strategy
- Global R&D Center
- Stem Cell GMP Center
Investors
- Investors
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Notice
- PR
- Press Release
- PR Resource Center

PR

PR Resource Center

Kangstem Biotech strives to develop an innovative new drug for patients suffering from rare and incurable diseases.

Search

No Data

Company

Company Overview

Welcome Message

Founder
CEO

Vision & Mission

Business

Stem Cell Therapy

Organoid

Stem Cell and CDMO Business

Health&Beauty Business

R&D

Core Technology

Global R&D Center

Stem Cell GMP Center

Investors

Notice

IR

PR